Should Bone Turnover Markers Be Used Routinely to Monitor Oral Bisphosphonate Osteoporosis Therapy? Yes: Measuring Adherence and Effectiveness of Therapy Benefits Patients

Am Fam Physician. 2023 Nov;108(5):442-443.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Oral
  • Biomarkers
  • Bone Density
  • Bone Density Conservation Agents* / therapeutic use
  • Bone Remodeling
  • Diphosphonates / therapeutic use
  • Female
  • Humans
  • Medication Adherence
  • Osteoporosis* / diagnosis
  • Osteoporosis* / drug therapy
  • Osteoporosis, Postmenopausal* / drug therapy

Substances

  • Diphosphonates
  • Bone Density Conservation Agents
  • Biomarkers